Investments
14Portfolio Exits
5Funds
3About Consonance Capital
Consonance Capital is a healthcare investment firm that invests broadly across the healthcare landscape. Private investments, which include growth equity, leveraged buyouts, and recapitalizations, are made under the direction of Consonance Capital Partners, a private equity manager led by Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. Public investments are made under the direction of Consonance Capital Management, a long/short public equity manager. Consonance Capital was established in 2005 and is located in New York City.
Latest Consonance Capital News
May 16, 2023
Consonance Capital makes partner promotion Submitted 16/05/2023 - 11:27am Consonance Capital Partners (CCP), a US healthcare-focused private equity firm, has promoted Sapna T Jethwa, who joined the business in 2012 and has been involved in the firm's investments in Enclara Health, Turn-Key Health, and Psychiatric Medical Care, to partner – business development. Over the past several years, Jethwa has led the firm’s business development efforts and driven CCP’s thematic sourcing model. Prior to joining CCP, she held positions at Bessemer Venture Partners, in JP Morgan’s Healthcare Investment Banking Group, and at The Monitor Group. Jethwa holds an MBA from The Wharton School and is a graduate of the Healthcare Management Program. Additionally, she holds a BAS in Biomedical Science from the University of Pennsylvania, School of Engineering & Applied Sciences and a BS in Economics with a concentration in Finance from the Wharton School. Like this article? Sign up to our free newsletter Author Profile Related Topics Intelligence People
Consonance Capital Investments
14 Investments
Consonance Capital has made 14 investments. Their latest investment was in Calviri as part of their Unattributed - III on November 11, 2021.
Consonance Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/9/2021 | Unattributed - III | Calviri | $11.08M | Yes | 2 | |
8/26/2021 | Seed VC | Sugar | $2.5M | Yes | Agya Ventures, Ben Zises, Claire Cormier Thielke, Concrete Rose Capital, Debut Capital, Diran Otegbade, Jonathan Wasserstrum, LAUNCH, Lightspeed Venture Partners, MetaProp, Oleksiy Ignatyev, The Community Fund, and Undisclosed Investors | 12 |
5/5/2021 | Seed VC | Lami | $1.8M | Yes | 16 | |
3/30/2021 | Seed VC - II | |||||
5/26/2020 | PIPE |
Date | 11/9/2021 | 8/26/2021 | 5/5/2021 | 3/30/2021 | 5/26/2020 |
|---|---|---|---|---|---|
Round | Unattributed - III | Seed VC | Seed VC | Seed VC - II | PIPE |
Company | Calviri | Sugar | Lami | ||
Amount | $11.08M | $2.5M | $1.8M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Agya Ventures, Ben Zises, Claire Cormier Thielke, Concrete Rose Capital, Debut Capital, Diran Otegbade, Jonathan Wasserstrum, LAUNCH, Lightspeed Venture Partners, MetaProp, Oleksiy Ignatyev, The Community Fund, and Undisclosed Investors | ||||
Sources | 2 | 12 | 16 |
Consonance Capital Portfolio Exits
5 Portfolio Exits
Consonance Capital has 5 portfolio exits. Their latest portfolio exit was Ladenburg Thalmann Financial Services on February 14, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/14/2020 | Take Private | 5 | |||
Date | 2/14/2020 | ||||
|---|---|---|---|---|---|
Exit | Take Private | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 5 |
Consonance Capital Acquisitions
6 Acquisitions
Consonance Capital acquired 6 companies. Their latest acquisition was Embark Behavioral Health on September 01, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
9/1/2022 | Acq - Fin | 3 | ||||
5/7/2015 | Series C | |||||
8/18/2014 | ||||||
8/18/2014 | ||||||
5/29/2014 |
Date | 9/1/2022 | 5/7/2015 | 8/18/2014 | 8/18/2014 | 5/29/2014 |
|---|---|---|---|---|---|
Investment Stage | Series C | ||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acq - Fin | ||||
Sources | 3 |
Consonance Capital Fund History
3 Fund Histories
Consonance Capital has 3 funds, including Consonance Private Equity II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
4/28/2020 | Consonance Private Equity II | Industry Focused | Open | $856M | 3 |
4/24/2020 | Consonance Private Equity PV II | ||||
7/21/2014 | Consonance Capital Healthcare Fund |
Closing Date | 4/28/2020 | 4/24/2020 | 7/21/2014 |
|---|---|---|---|
Fund | Consonance Private Equity II | Consonance Private Equity PV II | Consonance Capital Healthcare Fund |
Fund Type | Industry Focused | ||
Status | Open | ||
Amount | $856M | ||
Sources | 3 |
Consonance Capital Team
4 Team Members
Consonance Capital has 4 team members, including current Founder, Chief Executive Officer, Mitchell Blutt.
Name | Work History | Title | Status |
|---|---|---|---|
Mitchell Blutt | Founder, Chief Executive Officer | Current | |
Name | Mitchell Blutt | |||
|---|---|---|---|---|
Work History | ||||
Title | Founder, Chief Executive Officer | |||
Status | Current |
Loading...